OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 104 ALKS derivative securities | OQRO

Home
Insider trades
Alkermes plc
Officer exercised or converted 104 ALKS derivative securities

Insider trades

Insider trade

Officer exercised or converted 104 ALKS derivative securities

Traded Aug 3, 2026 · Filed Aug 3, 2026

ALKAlkermes plcALKS

104
Shares · @ $19.34

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 3, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 3, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001520262-26-000110

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Aug 3, 2026, 11:12 PM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Alkermes plc.

Issuer CIK

1520262

Ticker

ALKS

Reporting person

Craig C. Hopkinson

Relationship

Officer

Officer title

EVP R&D, Chief Medical Officer

Security

Ordinary Shares

Table

Non-derivative (Table I)

Transaction date

Aug 3, 2026

Transaction code

Shares / units

104

Price per share

$19.34

Acquired / disposed

Acquired (A)

Shares owned after

73,493

Ownership form

Direct

Amendment

Footnotes from the filing

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

Around the same time

Craig C. HopkinsonEVP R&D, Chief Medical Officer

Filed 5w ago

5,000Shares · @ $24.59

Traded Sep 1 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record

Craig C. Hopkinson (EVP R&D, Chief Medical Officer) sold ~$423K of Alkermes plc

Scheduled in advanceFiled 5w ago

Craig C. HopkinsonEVP R&D, Chief Medical Officer

Filed 5w ago

5,000Derivative units

Traded Sep 1 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record